Raymond Taetle

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Kazuhiro Morishita, Evan Parganas, Carroll L. William et al. · Proceedings of the National Academy of Sciences · 1992 · 279 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes

DA Carson, DB Wasson, Raymond Taetle et al. · Blood · 1983 · 273 citations · Full text

Pharmacy, Biochemistry, Toxicology +5

Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

Weidong Xu, Gary S. Firestein, Raymond Taetle et al. · Journal of Clinical Investigation · 1989 · 256 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.

Stephen B. Howell, Raymond Taetle · PubMed · 1981 · 170 citations

Medicine, Pharmacology, Toxicology +14